Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1998
10/15/1998CA2286452A1 Pyrimido-isoquinoline compounds with anticonvulsive action
10/15/1998CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998CA2286008A1 Anti-peptide antibody against human cytochrome p450 3a4
10/15/1998CA2285933A1 Assay for ligands to tyrosine kinase receptors
10/15/1998CA2285906A1 Hydroxamic acid derivatives
10/15/1998CA2285604A1 Somatostatin agonists
10/15/1998CA2285556A1 Calcilytic compounds
10/15/1998CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998CA2285388A1 Compounds
10/15/1998CA2285223A1 Somatostatin agonists
10/15/1998CA2285192A1 Pharmacological agents
10/15/1998CA2284996A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998CA2281843A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870831A1 Histidine kinase polypeptides
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870768A1 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
10/14/1998EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998EP0870759A1 Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them
10/14/1998EP0870504A2 New compositions comprising biologically active silicon
10/14/1998EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
10/14/1998EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin
10/14/1998EP0870035A2 A novel protein kinase required for ras signal transduction
10/14/1998EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998EP0870027A1 Novel c-mpl receptor agonists
10/14/1998EP0870023A1 Osteoprotegerin
10/14/1998EP0870019A2 Cell activation process and reagents therefor
10/14/1998EP0869972A1 Chemokine from niddm pancreas
10/14/1998EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998EP0869968A1 Growth-hormone secretagogues
10/14/1998EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives
10/14/1998EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/14/1998EP0869954A1 Novel heterocyclic compounds
10/14/1998EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/14/1998EP0869946A1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/14/1998EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents
10/14/1998EP0869944A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS
10/14/1998EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis
10/14/1998EP0869816A1 Dry compositions
10/14/1998EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
10/14/1998EP0869806A1 A pharmaceutical composition comprising plant worms and muirapuama
10/14/1998EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
10/14/1998EP0869799A1 Method and material for hair therapy
10/14/1998EP0869794A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
10/14/1998EP0869793A1 Hemoregulatory compounds
10/14/1998EP0869791A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
10/14/1998EP0869787A1 Vitronectin receptor antagonists
10/14/1998EP0869778A1 Improved perfluorocarbons for biological gas exchange and method
10/14/1998EP0752982B1 Biphenyl derivatives as 5ht1d antagonists
10/14/1998EP0741743B1 Cyclic neurokinin a antagonists
10/14/1998EP0678090B1 Piperazine derivatives
10/14/1998EP0673388B1 Double chain peptide compounds having hemoregulatory activity
10/14/1998EP0673366B1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
10/14/1998EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis
10/14/1998EP0577847B1 Morphinan derivative and medicinal use
10/14/1998EP0543861B1 Imidazopyridine derivatives, process for their preparation and their application
10/14/1998CN1196087A Novel protein HMW human MP52
10/14/1998CN1196057A Substituted phosphinic compounds and their use as pharmaceuticals
10/14/1998CN1196053A Novel heterocyclic compounds for treatment of pain and use thereof
10/14/1998CN1196049A Acylated derivatives of melatonin and its analogues, useful as medicaments
10/14/1998CN1195985A Benzimidazole compounds
10/14/1998CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof
10/14/1998CN1195523A 组合物 The composition
10/14/1998CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998CN1040211C Matrix metalloprotease inhibitors
10/14/1998CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract
10/13/1998US5821371 Heterocyclic compounds and their preparation and use
10/13/1998US5821370 Muscarinic cholinergic drugs
10/13/1998US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation
10/13/1998US5821331 Inhibit the proteolytic activity of proteases
10/13/1998US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998US5821256 Endothelin receptor antagonists
10/13/1998US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
10/13/1998US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
10/13/1998US5821250 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/13/1998US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
10/13/1998US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene
10/13/1998US5821230 GnRH antagonist decapeptides
10/13/1998US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998US5821225 Substituted at position 22-31 of amino acid sequence of a peptide of parathyroid hormone or parathyroid hormone related peptide
10/13/1998US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus
10/13/1998US5820858 Methods and compositions for inhibiting CD14 mediated cell activation
10/13/1998US5820849 Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes
10/13/1998CA2132578C Method of tumor treatment
10/13/1998CA1340082C Bovine interleukin-10c
10/10/1998CA2233524A1 Novel compounds
10/08/1998WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
10/08/1998WO1998044105A1 Polypeptide expressed in the horny layer of epidermis and use thereof